Cytodyn Inc (CYDY)

[daemon57]

Anyone else find this interesting? Why can't CYDY leverage this for basket???? Someone who has NP's ear needs to get this to HIM ASAP.


"
FDA Approves JEMPERLI (Dostarlimab-gxly) for Adult Patients with Mismatch Repair Deficient Recurrent or Advanced Endometrial Cancer

On April 22, 2021, the U.S. Food and Drug Administration (FDA) approved JEMPERLI (dostarlimab-gxly) for the treatment of adult patients with mismatch repair deficient (dMMR) recurrent or advanced endometrial cancer (EC), as determined by an FDA-approved test, that has progressed on or following prior treatment with a platinum-containing regimen. This indication is approved under accelerated approval based on tumor response rate and durability of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s)."

FDA approved test for cancer? Continued approval for this indication may be contingent?? Interesting....